A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2012-2015

ABSTRACT

The primary objective of this study is to evaluate the efficacy and safety of veliparib and whole brain radiation therapy in adults with brain metastases from non-small cell lung cancer (NSCLC).

URL

https://clinicaltrials.gov/show/NCT01657799

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The primary objective of this study is to evaluate the efficacy and safety of veliparib and whole brain radiation therapy in adults with brain metastases from non-small cell lung cancer (NSCLC).", 
    "endDate": "2015-01-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01657799", 
    "keywords": [
      "Double-Blind", 
      "Phase 2", 
      "dose", 
      "Evaluate", 
      "safety", 
      "efficacy", 
      "radiation therapy", 
      "non small cell lung cancer", 
      "primary objective", 
      "adult", 
      "brain metastasis", 
      "Non-Small-Cell Lung Carcinoma"
    ], 
    "name": "A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects With Brain Metastases From Non-Small Cell Lung Cancer", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01657799"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00012.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.431072.3", 
        "type": "Organization"
      }
    ], 
    "startDate": "2012-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s11060-016-2275-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037322260", 
          "https://doi.org/10.1007/s11060-016-2275-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-016-2275-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037322260", 
          "https://doi.org/10.1007/s11060-016-2275-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01657799"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01657799'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01657799'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01657799'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01657799'


 

This table displays all metadata directly associated to this object as RDF triples.

35 TRIPLES      16 PREDICATES      28 URIs      21 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01657799 schema:about anzsrc-for:3142
2 schema:description The primary objective of this study is to evaluate the efficacy and safety of veliparib and whole brain radiation therapy in adults with brain metastases from non-small cell lung cancer (NSCLC).
3 schema:endDate 2015-01-01T00:00:00Z
4 schema:keywords Double-Blind
5 Evaluate
6 Non-Small-Cell Lung Carcinoma
7 Phase 2
8 adult
9 brain metastasis
10 dose
11 efficacy
12 non small cell lung cancer
13 primary objective
14 radiation therapy
15 safety
16 schema:name A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects With Brain Metastases From Non-Small Cell Lung Cancer
17 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01657799
18 schema:sdDatePublished 2019-03-07T15:24
19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
20 schema:sdPublisher N8b0d19e522b14e06b0dcf1eb553f7715
21 schema:sponsor https://www.grid.ac/institutes/grid.431072.3
22 schema:startDate 2012-10-01T00:00:00Z
23 schema:subjectOf sg:pub.10.1007/s11060-016-2275-x
24 schema:url https://clinicaltrials.gov/show/NCT01657799
25 sgo:license sg:explorer/license/
26 sgo:sdDataset clinical_trials
27 rdf:type schema:MedicalStudy
28 N8b0d19e522b14e06b0dcf1eb553f7715 schema:name Springer Nature - SN SciGraph project
29 rdf:type schema:Organization
30 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
31 rdf:type schema:DefinedTerm
32 sg:pub.10.1007/s11060-016-2275-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037322260
33 https://doi.org/10.1007/s11060-016-2275-x
34 rdf:type schema:CreativeWork
35 https://www.grid.ac/institutes/grid.431072.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...